MK0859 Dose-Ranging Study (0859-003)

Clinical trial NCT00325455 · TERMINATED

Trial details

NCT number: NCT00325455
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia Mixed Hyperlipemia

Start date: 2006-06-01
Primary completion: 2007-02-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.